======= LPAR5 =======
== Gene Information ==
* **Official Symbol**: LPAR5
* **Official Name**: lysophosphatidic acid receptor 5
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57121|57121]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H1C0|Q9H1C0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LPAR5&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LPAR5|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606926|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities.
|7tm 1|
|behavioral response to pain|
|positive regulation of CREB transcription factor activity|
|response to pain|
|multicellular organismal response to stress|
|positive regulation of DNA-binding transcription factor activity|
|regulation of DNA-binding transcription factor activity|
|cellular component|
|behavior|
|G protein-coupled receptor activity|
|molecular function|
|G protein-coupled receptor signaling pathway|
|positive regulation of molecular function|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.51|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.88|
|[[:results:exp534|Trientine 500μM R08 exp534]]|-1.74|
|[[:results:exp124|GSK343 3μM R03 exp124]]|1.7|
|[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.87|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.92|
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.08|
|[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.24|
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|2.31|
|[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|2.73|
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|3.25|
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.93|
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|4.22|
^Gene^Correlation^
|[[:human genes:p:pdcl|PDCL]]|0.47|
|[[:human genes:p:ppp3r1|PPP3R1]]|0.459|
|[[:human genes:g:gna15|GNA15]]|0.42|
|[[:human genes:p:ppp3ca|PPP3CA]]|0.412|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18692
* **Expression level (log2 read counts)**: 5.31
{{:chemogenomics:nalm6 dist.png?nolink |}}